Dextran 40 and NovoLog FlexPen
Determining the interaction of Dextran 40 and NovoLog FlexPen and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dextran, low molecular weight
Brand name: LMD
Synonyms: n.a.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dextran 40-Novolog Injection
- Dextran 40-NovoLog Mix 70/30
- Dextran 40-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens))
- Dextran 40-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Vials))
- Dextran 40-NovoLog Mix 70/30 FlexPen
- Dextran 40-NovoLog PenFill
- NovoLog FlexPen-Dextran 70 6% in 5% Dextrose high molecular weight
- NovoLog FlexPen-Dextran 75
- NovoLog FlexPen-Dextran high molecular weight
- NovoLog FlexPen-Dextranomer and Hyaluronate Derivatives (Deflux)
- NovoLog FlexPen-Dextranomer and Hyaluronate Derivatives (Solesta)
- NovoLog FlexPen-Dextranomer and sodium hyaluronate